Rich is a serial entrepreneur at the intersection of engineering and biology. He is currently building a deeptech startup focused on democratizing access to autologous cell therapies through point-of-care manufacturing. He previously served as the founding Chief Scientific Officer at Resilience, a venture-backed biomanufacturing startup, and as the CSO of Synthego, a CRISPR genome engineering startup. Rich holds a Ph.D. in bioengineering from the University of Pittsburgh and completed a postdoctoral fellowship in Neurosciences at UC San Diego.